Acute coronary syndromes: Risk stratification and initial management

Cardiology Clinics

Volumn 23, Issue 4, 2005, Pages 401-409

  Cannon, Christopher P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALTEPLASE; ANTICOAGULANT AGENT; ANTITHROMBIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CLOPIDOGREL; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LISINOPRIL; NITRATE; RETEPLASE; STREPTOKINASE; TENECTEPLASE; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DEATH; DISEASE MARKER; ELECTROCARDIOGRAM; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; PRIORITY JOURNAL; REPERFUSION; RISK ASSESSMENT; SCORING SYSTEM; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS;

EID: 27644465167     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2005.08.006     Document Type: Review

References (54)

1. American Heart Association. Heart and stroke statistical update. American Heart Association, in press.
2. The TIMI IIIA Investigators Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial Circulation 87 1993 38 52
3. C.P. Cannon, W.S. Weintraub, and L.A. Demopoulos Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 25 2001 1879 1887
4. K.A. Fox, S.G. Goodman, and W. Klein Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 23 15 2002 1177 1189
5. J.H. Pope, R. Ruthazer, and J.R. Beshansky Clinical features of emergency department patients presenting with symptoms suggestive of acute cardia ischemia: a multicenter study J Thromb Thrombolysis 6 1998 63 74
6. M.C. Kontos, J.P. Ornato, and J.L. Tatum How many patients are eligible for treatment with GP IIb/IIIa inhibitors? Results from a clinical database Circulation 100 Suppl 1 1999 1 775
7. M.W. Pozen, R.B. D'Agostino, and H.P. Selker A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease. A prospective multicenter clinical trial N Engl J Med 310 1984 1273 1278
8. W.M. Tierney, B.J. Roth, and B. Psaty Predictors of myocardial infarction in emergency room patients Crit Care Med 13 1985 526 531
9. L. Goldman, E.F. Cook, and D.A. Brand A computer protocol to predict myocardial infarction in emergency department patients with chest pain N Engl J Med 318 1988 797 803
10. T.H. Lee, G. Juarez, and E.F. Cook Ruling out acute myocardial infarction. A prospective multicenter validation of a 12-hour strategy for patients at low risk N Engl J Med 324 1991 1239 1246
11. H.P. Selker, J.L. Griffith, and R.B. D'Agostino A time-insensitive predictive instrument for acute myocardial infarction mortality: a multicenter study Med Care 29 12 1991 1196 1211
12. F.P. Sarasin, J.M. Reymond, and J.L. Griffith Impact of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) on th speed of triage decision making for emergency department patients presenting with chest pain: a controlled clinical trial J Gen Intern Med 9 1994 187 194
13. H.P. Selker, J.R. Beshansky, and J.L. Griffith Use of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) to assist with triage of patients with chest pain or other symptoms suggestive of acute cardiac ischemia. A multicenter, controlled clinical trial Ann Intern Med 129 11 1998 845 855
14. L. Goldman, E.F. Cook, and P.A. Johnson Prediction of the need for intensive care in patients who come to emergency departments with acute chest pain N Engl J Med 334 23 1996 1498 1504
15. K.A. Fox, D.V. Cokkinos, and J. Deckers The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment Eur Heart J 21 2000 1440 1449
16. The Platelet Receptor Inhibition for Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction N Engl J Med 338 1998 1488 1497
17. The PURSUIT Trial Investigators Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes N Engl J Med 339 1998 436 443
18. E.M. Antman, C.H. McCabe, and E.P. Gurfinkel Enoxaparin prevents death and cardiac ischemic events in unstable Angina/Non-Q-wave myocardial infarction: results of the Thrombolysis In Myocardial Infarction (TIMI) 11B trial Circulation 100 15 1999 1593 1601
19. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb Investigators A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes N Engl J Med 335 1996 775 782
20. J.S. Hochman, C.H. McCabe, and P.H. Stone Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB J Am Coll Cardiol 30 1997 141 148
21. J.S. Hochman, J.E. Tamis, and T.D. Thompson Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators N Engl J Med 341 4 1999 226 232
22. B.M. Scirica, C.P. Cannon, and C.M. Gibson Assessing the effect of publication of clinical guidelines on the management of unstable angina and non-ST-elevation myocardial infarction in the TIMI III (1990-93) and the GUARANTEE (1995-96) registries Critical Pathways in Cardiology 1 2002 151 160
23. C.P. Cannon Evidence-based risk stratification to target therapies in acute coronary syndromes Circulation 106 13 2002 1588 1591
24. C.W. Hamm, C. Heeschen, and B. Goldmann Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels N Engl J Med 340 21 1999 1623 1629
25. C. Heeschen, C.W. Hamm, and B. Goldmann Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban Lancet 354 9192 1999 1757 1762
26. D.A. Morrow, C.P. Cannon, and N. Rifai Ability of minor elevations of troponin I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial JAMA 286 2001 2405 2412
27. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 7329 2002 71 86
28. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
29. A. Budaj, S. Yusuf, and S.R. Mehta Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups Circulation 106 2002 1622 1626
30. E. Boersma, K.S. Pieper, and E.W. Steyerberg Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients Circulation 101 2000 2557 2567
31. E.M. Antman, M. Cohen, and P.J. Bernink The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making JAMA 284 2000 835 842
32. D.A. Morrow, E.M. Antman, and S.M. Snapinn An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes: application of the TIMI Risk Score for US/NSTEMI in PRISM-PLUS Eur Heart J 23 3 2002 223 229
33. E. Braunwald, E.M. Antman, and J.W. Beasley ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Unstable Angina and Non-ST Segment Elevation Myocardial Infarction) J Am Coll Cardiol 36 2000 970 1056
34. P. Theroux, H. Ouimet, and J. McCans Aspirin, heparin or both to treat unstable angina N Engl J Med 319 1988 1105 1111
35. R. Peters, F. Zhao, and B.S. Lewis Aspirin dose and bleeding events in the CURE study Eur Heart J 4 Suppl 2002 510
36. S. Yusuf, S.R. Mehta, and F. Zhao Early and late effects of clopidogrel in patients with acute coronary syndromes Circulation 107 7 2003 966 972
37. S.R. Steinhubl, P.B. Berger, and J.T. Mann III Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 19 2002 2411 2420
38. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) Lancet 348 1996 1329 1339
39. E. Boersma, R.A. Harrington, and D.J. Moliterno Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials Lancet 359 2002 189 198
40. The GUSTO IV-ACS Investigators Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial Lancet 357 9272 2001 1915 1924
41. E. Braunwald, E.M. Antman, and J.W. Beasley ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) Circulation 106 14 2002 1893 1900
42. A. Oler, M.A. Whooley, and J. Oler Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis JAMA 276 1996 811 815
43. E.M. Antman, M. Cohen, and D. Radley Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction: TIMI 11B-ESSENCE meta-analysis Circulation 100 1999 1602 1608
44. S.G. Goodman, D. Fitchett, and P.W. Armstrong Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide Circulation 107 2003 238 244
45. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction Lancet 343 1994 1115 1122
46. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group ISIS-4: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction Lancet 345 1995 669 685
47. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study Lancet 354 9180 1999 708 715
48. F.J. Neumann, A. Kastrati, and G. Pogatsa-Murray Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial JAMA 290 2003 1593 1599
49. E.C. Keeley, J.A. Boura, and C.L. Grines Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials Lancet 361 9351 2003 13 20
50. H.R. Andersen, T.T. Nielsen, and K. Rasmussen A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction N Engl J Med 349 8 2003 733 742
51. P. Widimsky, T. Budesinsky, and D. Vorac Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2 Eur Heart J 24 1 2003 94 104
52. C.L. Grines, D.R. Westerhausen Jr., and L.L. Grines A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study J Am Coll Cardiol 39 11 2002 1713 1719
53. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Lancet 343 8893 1994 311 322
54. TIMI Study Group The Thrombolysis in Myocardial Infarction (TIMI) Trial; Phase I findings N Engl J Med 312 1985 932 936